Niagen Bioscience (NASDAQ:NAGE – Get Free Report) and Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership.
Volatility & Risk
Niagen Bioscience has a beta of 2.09, indicating that its stock price is 109% more volatile than the S&P 500. Comparatively, Nature’s Sunshine Products has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500.
Earnings and Valuation
This table compares Niagen Bioscience and Nature’s Sunshine Products”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Niagen Bioscience | $129.42 million | 1.93 | $17.38 million | $0.18 | 17.39 |
| Nature’s Sunshine Products | $480.14 million | 0.51 | $19.52 million | $1.01 | 13.73 |
Nature’s Sunshine Products has higher revenue and earnings than Niagen Bioscience. Nature’s Sunshine Products is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings for Niagen Bioscience and Nature’s Sunshine Products, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Niagen Bioscience | 0 | 1 | 3 | 1 | 3.00 |
| Nature’s Sunshine Products | 0 | 1 | 2 | 0 | 2.67 |
Niagen Bioscience currently has a consensus target price of $10.33, suggesting a potential upside of 230.14%. Nature’s Sunshine Products has a consensus target price of $30.50, suggesting a potential upside of 119.90%. Given Niagen Bioscience’s stronger consensus rating and higher probable upside, research analysts clearly believe Niagen Bioscience is more favorable than Nature’s Sunshine Products.
Profitability
This table compares Niagen Bioscience and Nature’s Sunshine Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Niagen Bioscience | 12.39% | 17.95% | 13.17% |
| Nature’s Sunshine Products | 3.68% | 12.88% | 8.17% |
Institutional & Insider Ownership
15.4% of Niagen Bioscience shares are owned by institutional investors. Comparatively, 79.4% of Nature’s Sunshine Products shares are owned by institutional investors. 10.0% of Niagen Bioscience shares are owned by insiders. Comparatively, 3.1% of Nature’s Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Niagen Bioscience beats Nature’s Sunshine Products on 11 of the 15 factors compared between the two stocks.
About Niagen Bioscience
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature’s Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature’s Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Receive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
